Research Article
Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two
Table 5
Multivariate analysis of adverse effects.
| Characteristic | B | SE | Wald | p | OR | 95% CI |
| Total AE | ≤3 months | | | | | 1 | | >3 months | −0.678 | 0.267 | 6.442 | 0.011 | 0.508 | 0.301–0.857 | Constant | −1.345 | 0.171 | 61.684 | 0 | 0.261 | |
| GI | Constant | −2.098 | 0.153 | 188.088 | <0.001 | 0.123 | |
| CNS effect | ≤3 months | | | | | 1 | | >3 months | −1.196 | 0.485 | 6.079 | 0.014 | 0.303 | 0.117–0.783 | Constant | −2.424 | 0.253 | 91.785 | <0.001 | 0.089 | |
|
|
Binary logistic regression model with a variable entry criterion of 0.05 and an emission standard of 0.10.
|